Harvard Bioscience, Inc.
HBIO
$6.04
$0.030.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.60% | 26.36% | -8.40% | 34.19% | 35.00% |
| Total Receivables | -9.17% | 32.49% | 1.44% | -11.44% | -9.33% |
| Inventory | 6.73% | -3.70% | -2.93% | -2.46% | -1.85% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 30.44% | -15.63% | -1.80% | 8.95% | 5.62% |
| Total Current Assets | -1.55% | 10.09% | -2.59% | 0.15% | -0.48% |
|
|
|||||
| Total Current Assets | -1.55% | 10.09% | -2.59% | 0.15% | -0.48% |
| Net Property, Plant & Equipment | -3.01% | -4.25% | 3.70% | -2.02% | 9.38% |
| Long-term Investments | -1.96% | 0.36% | -6.18% | 13.30% | -84.09% |
| Goodwill | -1.96% | 0.36% | -6.18% | 13.30% | -84.09% |
| Total Other Intangibles | -9.60% | -8.83% | -8.32% | -9.78% | -9.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.98% | -29.11% | 0.11% | 7.73% | 24.14% |
| Total Assets | -2.66% | 2.67% | -2.62% | 0.37% | -36.99% |
|
|
|||||
| Total Accounts Payable | 44.77% | -29.44% | 9.61% | -1.79% | 0.44% |
| Total Accrued Expenses | -16.14% | 52.27% | -17.43% | 7.12% | 16.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.77% | -95.70% | -2.38% | -2.84% | -1.93% |
| Total Finance Division Other Current Liabilities | 6.16% | 15.70% | 0.86% | 5.17% | 9.99% |
| Total Other Current Liabilities | 6.16% | 15.70% | 0.86% | 5.17% | 9.99% |
| Total Current Liabilities | 8.67% | -59.63% | -1.46% | -0.72% | 1.17% |
|
|
|||||
| Total Current Liabilities | 8.67% | -59.63% | -1.46% | -0.72% | 1.17% |
| Long-Term Debt | 0.95% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.60% | -6.14% | 4.79% | -3.22% | 13.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.22% | -26.00% | 3.73% | -0.75% | 14.31% |
| Total Liabilities | 2.34% | 3.77% | -0.68% | -0.93% | 2.63% |
|
|
|||||
| Common Stock & APIC | 0.16% | 0.73% | 0.13% | 0.22% | 0.22% |
| Retained Earnings | -1.59% | -1.34% | -0.58% | -1.10% | -31.86% |
| Treasury Stock & Other | -5.49% | 6.15% | -6.28% | 18.52% | 8.35% |
| Total Common Equity | -26.85% | -2.37% | -10.58% | 6.05% | -76.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.85% | -2.37% | -10.58% | 6.05% | -76.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.85% | -2.37% | -10.58% | 6.05% | -76.58% |
|
|
|||||